Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 2
1(25.0%)
4Total
N/A(3)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04491175Not ApplicableCompleted

Impact of DuoTherm on Opioid Use and Low Back Pain

Role: lead

NCT04494698Not ApplicableCompleted

Impact of DuoTherm Compared to TENS on Pain and Disability With Acute and Chronic Low Back Pain

Role: lead

NCT04494841Not ApplicableCompleted

Usability of a Multimodal External Neuromodulatory Device to Relieve Acute Low Back Pain

Role: lead

NCT01152489Phase 2Completed

A Test of the Effectiveness of a Device and Distraction for Pediatric Immunization Pain

Role: lead

All 4 trials loaded